Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Lawrie

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Heart (British Cardiac Society)|May 5, 2022
Right ventricular remodelling in pulmonary arterial hypertension predicts treatment responseZe Ming Goh, Nithin Balasubramanian, Samer Alabed, et al.
Pulmonary Circulation|April 19, 2019
The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE RegistryCatherine G Billings, Robert Lewis, Judith A Hurdman, et al.
American Journal of Respiratory and Critical Care Medicine|December 11, 2012
Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertensionChristopher J Rhodes, John Wharton, Reinier A Boon, et al.
Nature Communications|December 31, 2025
Endoglin as a BMP9 co-receptor in vascular endothelial cells: prodomain displacement and TGFBRII recruitmentJingxu Guo, Karolina Kostrzyńska, Ioannis Kamzolas, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2022
Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial HypertensionChristopher J Rhodes, John Wharton, Emilia M Swietlik, et al.
Annals of the American Thoracic Society|September 14, 2020
Maximal Exercise Testing Using the Incremental Shuttle Walking Test Can Be Used to Risk-Stratify Patients with Pulmonary Arterial HypertensionRobert A Lewis, Catherine G Billings, Judith A Hurdman, et al.
Thrombosis and Haemostasis|April 15, 2016
Heart rate reduction with ivabradine promotes shear stress-dependent anti-inflammatory mechanisms in arteriesLe Luong, Hayley Duckles, Torsten Schenkel, et al.
Frontiers in Cardiovascular Medicine|April 11, 2022
Imaging and Risk Stratification in Pulmonary Arterial Hypertension: Time to Include Right Ventricular AssessmentFaisal Alandejani, Abdul Hameed, Euan Tubman, et al.
Nature Cardiovascular Research|August 28, 2024
Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertensionFatemeh Khassafi, Prakash Chelladurai, Chanil Valasarajan, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 2022
Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial HypertensionLars Harbaum, Christopher J Rhodes, John Wharton, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Heart (British Cardiac Society)|May 5, 2022
Right ventricular remodelling in pulmonary arterial hypertension predicts treatment responseZe Ming Goh, Nithin Balasubramanian, Samer Alabed, et al.
Pulmonary Circulation|April 19, 2019
The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE RegistryCatherine G Billings, Robert Lewis, Judith A Hurdman, et al.
American Journal of Respiratory and Critical Care Medicine|December 11, 2012
Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertensionChristopher J Rhodes, John Wharton, Reinier A Boon, et al.
Nature Communications|December 31, 2025
Endoglin as a BMP9 co-receptor in vascular endothelial cells: prodomain displacement and TGFBRII recruitmentJingxu Guo, Karolina Kostrzyńska, Ioannis Kamzolas, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2022
Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial HypertensionChristopher J Rhodes, John Wharton, Emilia M Swietlik, et al.
Annals of the American Thoracic Society|September 14, 2020
Maximal Exercise Testing Using the Incremental Shuttle Walking Test Can Be Used to Risk-Stratify Patients with Pulmonary Arterial HypertensionRobert A Lewis, Catherine G Billings, Judith A Hurdman, et al.
Thrombosis and Haemostasis|April 15, 2016
Heart rate reduction with ivabradine promotes shear stress-dependent anti-inflammatory mechanisms in arteriesLe Luong, Hayley Duckles, Torsten Schenkel, et al.
Frontiers in Cardiovascular Medicine|April 11, 2022
Imaging and Risk Stratification in Pulmonary Arterial Hypertension: Time to Include Right Ventricular AssessmentFaisal Alandejani, Abdul Hameed, Euan Tubman, et al.
Nature Cardiovascular Research|August 28, 2024
Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertensionFatemeh Khassafi, Prakash Chelladurai, Chanil Valasarajan, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 2022
Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial HypertensionLars Harbaum, Christopher J Rhodes, John Wharton, et al.
Pageof 12